Piromelatine

· Neurim Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Piromelatine, covering 2024-06-21 to 2024-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) [Phase 2]